Page 76 - Registration Document News Today

Investegate announcements from Natwest Markets PLC, NWM Plc Registration Document and Base Prospectus

Regulatory News: Mercialys (Paris:MERY) filed its 2022 Universal Registration Document with the French Financial Markets Authority (AMF) on March 14, 2023, under number D.23-0091. The 2022 Universal

GenSight Biologics pushed back regulatory dates because of an operational issue at CDMO Brammer Bio, a subsidiary of Thermo Fisher.

Specialized in low-carbon hydrogen production and distribution equipment (electrolyzers and refueling stations), today announces its consolidated...

Sibnayal® (potassium citrate/potassium bicarbonate) has been launched on March 1, 2023Reference price equals to an annual treatment cost of €15,000 per patient.PARIS--(BUSINESS WIRE)--Regulatory News:Advicenne (Euronext Growth Paris ALDVI - FR0013296746), a specialty pharmaceutical company dedicated to the developme...

Sibnayal (potassium citrate/potassium bicarbonate) has been launched on March 1, 2023 Reference price equals to an annual treatment cost of €15,000 per patient. Regulatory News: Advicenne

BONDUELLE A French SCA (Partnership Limited by Shares) with a capital of 57 102 699,50 EurosHead Office: La Woestyne 59173 Renescure, FranceRegistered under number: 447 250 044 (Dunkerque Commercial

         Meudon (France), March 2, 2023 Fourth Quarter and Full Year 2022 Results FY 2022 results in-line with objectives with EBITDA of €312 million in Q4 and

Press ReleaseMarch 2, 2023 - N° 4 2022 Annual Results SCOR ends 2022 with a net income of EUR 208 million in Q4 and proposes a dividend of EUR 1.40 per share Gross written premiums

DJ Affluent Medical: Affluent Medical announces the major success of its capital increase with preferential subscription rights for about EUR13.7 million Affluent Medical Affluent Medical: Affluent